Overview

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Allogeneic Non-Myeloablative Stem Cell Transplantation Using Fludarabine and Melphalan Conditioning Regimen for Chronic Lymphocytic Leukemia, Lymphoma, and Multiple Myeloma
Phase:
Phase 2
Details
Lead Sponsor:
Cooperative Study Group A for Hematology
Treatments:
Fludarabine
Fludarabine phosphate
Melphalan
Vidarabine